Data from the current study showed that activation of p53 mediates PRMT1 ubiquitination-dependent degradation via inhibition of USP7 in response to glucose insufficiency in p53 wild-type NSCLC cells. This evidence concerns the gene TP53 and non-small cell lung carcinoma.